Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center-Reference-Cited by-同舟云学术

Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center

Published:2015-08 Issue:4 Volume:13 Page:385-391.e1
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Necchi Andrea,Farè Elena,Vullo Salvatore Lo,Giannatempo Patrizia,Raggi Daniele,Nicolai Nicola,Piva Luigi,Biasoni Davide,Catanzaro Mario,Torelli Tullio,Stagni Silvia,Maffezzini Massimo,Verzoni Elena,Grassi Paolo,Procopio Giuseppe,Pizzocaro Giorgio,Mariani Luigi,Salvioni Roberto

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group;J Clin Oncol,1997

2. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide;Williams;N Engl J Med,1987

3. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol;Nichols;J Clin Oncol,1991

4. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B study;Nichols;J Clin Oncol,1998

5. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Effect of Bleomycin Administration on the Development of Pulmonary Toxicity in Patients With Metastatic Germ Cell Tumors Receiving First-Line Chemotherapy: A Meta-Analysis of Randomized Studies;Clinical Genitourinary Cancer;2017-04

3. The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?;Clinical Genitourinary Cancer;2016-02

4. Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation;Urologic Oncology: Seminars and Original Investigations;2015-07